Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether chromoendoscopy using Indigo-Carmine dye spray is useful in diagnosing microscopic colitis among patients undergoing colonoscopy due to chronic watery diarrhea.


Clinical Trial Description

Microscopic colitis is a common disease found in 10% to 20% of cases having chronic watery diarrhea. Obvious endoscopically identifiable changes of the mucosal surface are usually absent, thus diagnosing microscopic colitis relies on multiple biopsy sampling from all segments of the colon. Chromoendoscopy using indigo-carmine dye spray might, however, unravel mucosal changes in microscopic colitis (Suzuki 2011).

The aim of this study is to investigate if chromoendoscopy using Indigo-Carmine 0.2-0.5% in patients with chronic watery diarrhea is useful in diagnosing microscopic colitis. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01504048
Study type Interventional
Source Karolinska University Hospital
Contact Peter T Schmidt, MD, PhD
Phone +46 8 51770000
Email peter.thelin.schmidt@ki.se
Status Recruiting
Phase N/A
Start date June 2009
Completion date December 2016

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00139165 - Long-Term Treatment of Collagenous Colitis With Budesonide Phase 3
Not yet recruiting NCT03658993 - Rifaximin-treatment of Collagenous Colitis Phase 3
Completed NCT00450086 - Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis Phase 3
Completed NCT01928667 - Case-Control Study to Identify Risk Factors for Microscopic Colitis N/A
Completed NCT00180076 - Budesonide for Maintenance Treatment of Collagenous Colitis Phase 3